Update from San Francisco 2018
GU CONNECT has summarised the highlights of the recent ASCO GU 2018 meeting for you.
Non-metastatic castration-resistant prostate cancer (M0 CRPC) by Prof. Evan Y. Yu, University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, USA
Urothelial carcinoma (UC) by Asst. Prof. Shilpa Gupta, Masonic Cancer Center, University of Minnesota, USA
Renal cell carcinoma (RCC) by Prof. David Pfister, University Hospital of Cologne, Germany